-
Mashup Score: 0
Find approved medications research related to long-acting antiretroviral agents used in HIV treatment and prevention.
Source: hivlaa.orgCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 6
Find resources relating to long acting agents workflows including SOPs, medical necessity letters, tracking documents, and explainer videos.
Source: hivlaa.orgCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 0Clinical Data & Research | AAHIVM Long-Acting Agents Resource Center - 10 month(s) ago
Find information on clinical data and research relating to long-acting antiretroviral agents used for HIV treatment.
Source: hivlaa.orgCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 1Prescribing Guidelines | AAHIVM Long-Acting Agents Resource Center - 11 month(s) ago
Access prescribing guidelines for long-acting agents used in HIV care, including Apretude for PrEP and Cabenuva for treatment.
Source: hivlaa.orgCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 0Patient Information | AAHIVM Long-Acting Agents Resource Center - 1 year(s) ago
Discover additional information for patients including long-acting agent HIV treatment FAQs, PrEP FAQs, social media videos, and more.
Source: hivlaa.orgCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 2
Find approved medications research related to long-acting antiretroviral agents used in HIV treatment and prevention.
Source: hivlaa.orgCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 5Cabenuva | AAHIVM Long-Acting Agents Resource Center - 1 year(s) ago
Access prescribing guidelines regarding safe use of Cabenuva for long-acting treatment of HIV-1 infection.
Source: hivlaa.orgCategories: General Medicine News, Infectious DiseaseTweet
Are you a prescriber or patient interested in the research about #HIVLAA? Take a look at the available studies about long-acting agents #Apertude, #Cabenuva, and #Trogarzo in Long-Acting Agent Resource Center today: https://t.co/YrS8d9KBSZ https://t.co/TLmNDAMnzE